What is CONOCE+® 2026 — Oncología en la Era de la IA?
CONOCE+® 2026 — Oncología en la Era de la IA is a specialized medical congress focused on the integration of artificial intelligence in oncological practice, scheduled to take place from August 13-15, 2026, in Querétaro, Querétaro, Mexico. This congress represents a pivotal gathering for healthcare professionals seeking to understand and implement AI-driven solutions in cancer diagnosis, treatment protocols, and patient management systems.
Organized by Congresos MPR (Medical Research & Pharma), this three-day event is designed to bridge the gap between cutting-edge artificial intelligence technologies and practical oncological applications. The congress attracts over 500 participants, including oncologists, radiologists, pathologists, medical researchers, healthcare administrators, and technology specialists working at the intersection of AI and cancer care.
Key Focus Areas of CONOCE+® 2026
AI in Cancer Diagnosis
The congress extensively covers artificial intelligence applications in early cancer detection and diagnostic accuracy improvement. Sessions explore machine learning algorithms for medical imaging interpretation, including:
- Deep learning models for radiological image analysis
- AI-powered pathology slide interpretation
- Predictive algorithms for cancer risk assessment
- Computer-aided detection systems in screening programs
- Integration of multi-modal diagnostic data
AI-Driven Treatment Protocols
CONOCE+® 2026 examines how artificial intelligence is revolutionizing cancer treatment approaches through personalized medicine and precision oncology:
- Genomic data analysis for targeted therapy selection
- Predictive modeling for treatment response
- AI-assisted surgical planning and navigation
- Automated chemotherapy dosing optimization
- Machine learning in radiotherapy treatment planning
- Drug discovery acceleration through AI platforms
Healthcare Management and AI Integration
The congress addresses the operational aspects of implementing AI solutions in oncology departments and healthcare systems. Topics include workflow optimization, resource allocation, and quality assurance in AI-supported cancer care environments.
Target Audience for CONOCE+® 2026 — Oncología en la Era de la IA
Primary Healthcare Professionals
The congress primarily serves medical oncologists, radiation oncologists, and surgical oncologists who are integrating or considering the implementation of AI tools in their clinical practice. These professionals attend to understand evidence-based applications of artificial intelligence in patient care and treatment decision-making.
Diagnostic Specialists
Radiologists and pathologists constitute a significant portion of CONOCE+® 2026 attendees, as AI applications in medical imaging and histopathological analysis represent rapidly evolving fields with immediate clinical relevance.
Research and Academic Community
Medical researchers, biomedical engineers, and academic clinicians participate to present research findings, explore collaborative opportunities, and understand the translational aspects of AI technologies in oncological research.
Healthcare Technology Professionals
Information technology specialists, healthcare administrators, and medical device professionals attend to understand implementation challenges, regulatory requirements, and integration strategies for AI systems in oncological care settings.
Scientific Program Structure
Plenary Sessions
CONOCE+® 2026 features comprehensive plenary sessions addressing foundational concepts in AI applications for oncology. These sessions provide broad overviews of current capabilities, limitations, and future directions in the field.
Specialized Workshops
Hands-on workshops allow participants to interact with AI platforms, analyze case studies, and develop practical skills in implementing artificial intelligence tools in clinical scenarios.
Poster Presentations
The congress includes extensive poster presentation sessions showcasing original research, clinical case studies, and innovative applications of AI in oncological practice from institutions across Latin America and beyond.
Industry Exhibition
Technology vendors, pharmaceutical companies, and medical device manufacturers present their AI-powered solutions, providing attendees with direct access to commercial platforms and emerging technologies.
Therapeutic Areas Covered
Solid Tumor Management
CONOCE+® 2026 extensively covers AI applications in major solid tumors, including:
- Breast cancer screening and treatment optimization
- Lung cancer early detection and staging
- Colorectal cancer diagnosis and surgical planning
- Prostate cancer risk stratification
- Brain tumor classification and treatment planning
Hematological Malignancies
Sessions address artificial intelligence applications in blood cancers, focusing on diagnostic accuracy, treatment selection, and monitoring approaches for leukemias, lymphomas, and multiple myeloma.
Pediatric Oncology
Specialized sessions examine the unique considerations and applications of AI in pediatric cancer care, including age-specific diagnostic challenges and treatment optimization for childhood malignancies.
Regulatory and Ethical Considerations
AI Validation and Approval Processes
CONOCE+® 2026 addresses the regulatory landscape surrounding AI medical devices and software, including FDA approval pathways, European CE marking requirements, and Mexican regulatory frameworks (COFEPRIS guidelines).
Ethical AI Implementation
Sessions explore ethical considerations in AI-driven oncological care, including algorithm bias, patient consent for AI-assisted diagnosis, data privacy, and the physician-AI relationship in clinical decision-making.
Quality Assurance and Safety
The congress examines quality control measures for AI systems, validation protocols, and safety monitoring in clinical implementations of artificial intelligence tools.
Research and Innovation Highlights
Emerging AI Technologies
CONOCE+® 2026 showcases cutting-edge developments in artificial intelligence applied to oncology, including:
- Generative AI for treatment protocol development
- Multimodal AI systems combining imaging, genomics, and clinical data
- Real-time AI monitoring during surgical procedures
- Predictive models for treatment-related adverse events
- AI-powered clinical trial matching and patient recruitment
Collaborative Research Initiatives
The congress facilitates networking and collaboration between research institutions, promoting multi-center studies and data sharing initiatives that advance AI applications in oncology.
Preparing for CONOCE+® 2026 — Oncología en la Era de la IA
Pre-Congress Preparation
Effective preparation for CONOCE+® 2026 involves reviewing current literature on AI applications in oncology, familiarizing oneself with basic machine learning concepts, and identifying specific areas of interest within the broad spectrum of AI-oncology applications.
Essential Background Knowledge
Attendees benefit from understanding fundamental concepts including:
- Machine learning algorithms (supervised, unsupervised, reinforcement learning)
- Deep learning and neural network architectures
- Medical imaging informatics and DICOM standards
- Genomic data analysis and bioinformatics
- Healthcare data standards and interoperability
Technical Preparation
For workshop participation, attendees should ensure familiarity with basic statistical software and, where possible, programming languages commonly used in medical AI applications such as Python or R.
Professional Development Opportunities
Healthcare professionals preparing to present at CONOCE+® 2026 can benefit from specialized preparation programs. Leaderlix Health, operating across 21 countries and founded by Gerardo Betancourt (TED Former Ambassador), provides pre-congress speaker preparation services for medical professionals presenting at international oncology conferences. Their programs focus on effective scientific communication, presentation skills enhancement, and audience engagement strategies specifically tailored for healthcare congress presentations.
Impact on Clinical Practice
Implementation Strategies
CONOCE+® 2026 provides practical guidance for healthcare institutions considering AI implementation, including technology assessment, staff training requirements, infrastructure needs, and change management strategies.
Cost-Effectiveness Analysis
Sessions examine the economic implications of AI adoption in oncology, including cost-benefit analyses, budget planning, and return on investment calculations for healthcare administrators.
Patient Outcomes and Quality Metrics
The congress addresses measurement and evaluation of AI impact on patient care, including clinical outcome metrics, quality indicators, and patient satisfaction measures in AI-supported oncological practice.
Future Directions and Trends
Emerging Technologies
CONOCE+® 2026 explores future developments in AI-oncology applications, including quantum computing applications, advanced natural language processing for clinical documentation, and integration of Internet of Things (IoT) devices in cancer monitoring.
Global Perspectives
International speakers and participants contribute diverse perspectives on AI implementation challenges and successes across different healthcare systems, regulatory environments, and resource settings.
Next-Generation Training
The congress addresses educational needs for training the next generation of oncologists in AI-integrated practice, including curriculum development, competency frameworks, and continuing medical education requirements.
Networking and Collaboration
Professional Connections
CONOCE+® 2026 facilitates meaningful professional networking through structured networking sessions, collaborative workspaces, and special interest group meetings focused on specific AI applications or cancer types.
Industry-Academic Partnerships
The congress promotes partnerships between academic medical centers, research institutions, and technology companies, fostering translation of research findings into clinical applications.
International Collaboration
With participants from across Latin America and international speakers, CONOCE+® 2026 serves as a platform for establishing international research collaborations and knowledge exchange initiatives in AI-oncology applications.